title: β-blockers in postoperative myocardial diastolic dysfunction: not a panacea.
abstract: Successful treatment with heart rate lowering medication has been used to treat adults with chronic myocardial dysfunction of various aetiologies for a number of years. There has been recent evidence for the successful use of β-receptor blocking medication in highly selected group of infants with diastolic myocardial dysfunction. This case series demonstrates that while the use of β-receptor blockers in infants early following initial treatment of congenital left heart obstructive lesions appears promising and safe adjunct to more conventional management, the medium-term and long-term care of these patients remains as challenging as before.
authors.affiliation: Royal Brompton Hospital, London, UK.
authors.forename: Salim G M
authors.initials: SG
authors.lastname: Jivanji
authors.affiliation: Royal Brompton Hospital, London, UK.
authors.forename: Zdenek
authors.initials: Z
authors.lastname: Slavik
authors.affiliation: Department of PICU, Royal Brompton Hospital, London, UK.
authors.forename: Anke
authors.initials: A
authors.lastname: Furck
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D003971:Diastole; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy*; D011412:Propanolamines / Q000627:therapeutic use*; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C036604:esmolol